I’ve recurrent episcleritis, a migrating polyarticular arthritis, and a leukocytoclastic small-vessel vasculitis. I switched to Entyvio in Nov 2016. I’ve been on sulfasalazine, Apriso, and Lialda, and now back to sulfa (dose recently doubled).
Hey UC’ers, Here is a study that caught my eye. Especially considering the skin lesions (skin rash, eczema) issues I dealt with after starting Humira about 7 years ago. I was a bit shocked to read that one third of… Read More »33% of IBD Patients Will Experience Skin Lesions at Some Point
Happy 4th of July to all the American based or celebrating UC’ers of the world. There have been some questions over the past few weeks with regards to a relatively new medication call “Entyvio” or sometimes Vedolizumab (and I’m sure… Read More »Information about Entyvio or Vedolizumab (New Medication)
(If you’ve taken Entyvio / Vedolizumab, please submit a “review” of your experience via the button at the bottom of this post:) There has been some recent news breaking the airwaves/internet waves about some clinical study data which you may… Read More »Entyvio or “Vedolizumab” Reviews – the Integrin Antagonist